Improving Clinical Outcomes: Next Generation Sequencing and Pharmacogenomics

by Brooks | Jul 6, 2025 | Clinical outcomes, Emerging Trends, Next generation sequencing, Pharmacogenomics, Reduce Adverse Drug Reactions

Jennifer Tovar, PharmD & Husna Rahim, PharmD Improving Clinical Outcomes: Next Generation Sequencing and Pharmacogenomics. How has Next Generation Sequencing (NGS) transformed the field of pharmacogenomics (PGx)? NGS, also known as massive parallel sequencing, is...

Pharmacogenomics: Rethinking Mental Health

by Brooks | Jul 6, 2025 | Emerging Trends, Mental Health and Psychiatry, Pharmacogenomics

Jennifer Tovar, PharmD & Hanna M. Schultze, MD, DE, EMBA Pharmacogenomics: Rethinking Mental Health. How might pharmacogenomics (PGx) reshape the treatment paradigm for mental health disorders? Mental health PGx is a rapidly evolving field at the intersection of...

Pharmacogenomics: Ensuring Equitable Benefits for Underserved Patient Populations

by Brooks | Jul 6, 2025 | Emerging Trends, Inequities - Underrepresented, Pharmacogenomics

Zachary Brooks, PhD & Archana Gurudu Pharmacogenomics: Ensuring Equitable Benefits for Underserved Patient Populations. How can pharmacogenomic (PGx) research and testing promote health equity in patients of underserved backgrounds? PGx remains a foundational...

Mental Health in Pregnancy: Advancing Care Through Pharmacogenomics

by Brooks | May 22, 2025 | Emerging Trends, Mental Health and Psychiatry, Women's Health

Miley Nguyen, PharmD & Husna Rahim, PharmD Mental Health in Pregnancy: Advancing Care Through Pharmacogenomics. How can pharmacogenomics (PGx) enhance mental health treatment during pregnancy? Hormonal fluctuations during pregnancy significantly increase the risk...

Pharmacogenomics for Smarter Drug Discovery

by Brooks | Apr 25, 2025 | Drug Discovery, Emerging Trends

Zachary S. Brooks, PhD, EMBA & Panashe Nyengera Pharmacogenomics for Smarter Drug Discovery. What if drug development began with the patient already in mind? Pharmacogenomics (PGx) merges genomics with pharmacology to refine drug development by linking genetic...

Pharmacogenomics in Rare Disease: Challenges and Opportunities

by Brooks | Apr 16, 2025 | Emerging Trends, Rare disease

Chris Moore, MBA & Jayden Lee, EMBA, BCACP, PharmD Pharmacogenomics in Rare Disease: Challenges and Opportunities. How rare is rare? In the U.S. alone, around 30 million people – roughly 1 in 10 – live with a rare disease (Rare Disease, NIH, 2025). 80% of rare...